Eriksson, Bengt I <br/><br/>
Dabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: a pooled analysis.  [electronic resource] 

 -  Thrombosis research  Nov 2012 
 - 818-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-2472 
<br/><br/><label>Standard No.: </label>10.1016/j.thromres.2012.07.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Arthroplasty, Replacement, Hip--adverse effects<br/>Arthroplasty, Replacement, Knee--adverse effects<br/>Benzimidazoles--adverse effects<br/>Body Mass Index<br/>Clinical Trials, Phase III as Topic<br/>Dabigatran<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Obesity--blood<br/>Postoperative Complications--prevention & control<br/>Risk Factors<br/>Treatment Outcome<br/>Venous Thromboembolism--drug therapy<br/>beta-Alanine--adverse effects